Kari L. Anderl
- Genetics top 10%
- Glioma Diagnosis and Treatment 4
-
- Cancer Genomics and Diagnostics 5
-
- Renal cell carcinoma treatment 4
- Sarcoma Diagnosis and Treatment 1
-
- Renal and related cancers 4
- DNA Repair Mechanisms 1
- Hedgehog Signaling Pathway Studies 1
-
- Cancer-related Molecular Pathways 3
- Co-authors
- Robert B. JenkinsThomas J. BorellDavid G. BostwickJunqi QianJames A. BrownBernd W. ScheithauerMichael M. LieberJohn F. Herath
- Journals
- Gastroenterology (1 paper)The Journal of Urology (4 papers)Journal of Neuropathology & Experimental Neurology (1 paper)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Kari L. Anderl
11 papers receiving 382 citations
Peers
Comparison fields: 5 of 51
- Genetics 118
- Cancer Research 117
- Pulmonary and Respiratory Medicine 223
- Molecular Biology 239
- Oncology 78
Countries citing papers authored by Kari L. Anderl
This map shows the geographic impact of Kari L. Anderl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari L. Anderl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari L. Anderl more than expected).
Fields of papers citing papers by Kari L. Anderl
This network shows the impact of papers produced by Kari L. Anderl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari L. Anderl. The network helps show where Kari L. Anderl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kari L. Anderl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 70 | |
| 2 | 2001 | 1 | |
| 3 | 2000 | 33 | |
| 4 | Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridol. | 2000 | 43 |
| 5 | 1999 | 36 | |
| 6 | 1997 | 3 | |
| 7 | Detection of p16 gene deletions in gliomas: Fluorescence in situ hybridization (FISH) versus quantitative PCR | 1997 | 1 |
| 8 | 1997 | 62 | |
| 9 | 1996 | 98 | |
| 10 | 1996 | 2 | |
| 11 | 1996 | 43 |
About Kari L. Anderl
Kari L. Anderl is a scholar working on Genetics, Cancer Research and Pulmonary and Respiratory Medicine, having authored 11 papers that have together received 392 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (5 papers), Renal cell carcinoma treatment (4 papers), Glioma Diagnosis and Treatment (4 papers), Renal and related cancers (4 papers), Cancer-related Molecular Pathways (3 papers), Sarcoma Diagnosis and Treatment (1 paper), DNA Repair Mechanisms (1 paper) and Hedgehog Signaling Pathway Studies (1 paper). The work is most often cited by research in Genetics (118 citations), Cancer Research (117 citations) and Pulmonary and Respiratory Medicine (223 citations). Kari L. Anderl has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Robert B. Jenkins, Thomas J. Borell, David G. Bostwick, Junqi Qian, James A. Brown, Bernd W. Scheithauer, Michael M. Lieber, John F. Herath, Anton K. Raap and Rudolf H. Boerman. Their work appears in journals such as Gastroenterology, The Journal of Urology and Journal of Neuropathology & Experimental Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.